Effects of carnitine on glucose and lipid metabolic profiles and fertility outcomes in women with polycystic ovary syndrome: A systematic review and meta‐analysis

To quantify the effect of carnitine on glucose and lipid metabolic profiles and fertility outcomes in women with Polycystic ovary syndrome (PCOS).

[1]  M. Tang,et al.  Carnitine and Depression , 2022, Frontiers in Nutrition.

[2]  Abbas Ali Sangouni,et al.  The effect of l-carnitine supplementation on insulin resistance, sex hormone-binding globulin and lipid profile in overweight/obese women with polycystic ovary syndrome: a randomized clinical trial , 2021, European Journal of Nutrition.

[3]  D. Liao,et al.  Clinical evidence of the effects of carnitine supplementation on body weight, glycemic control and serum lipids in women with polycystic ovary syndrome: a systematic review and meta-analysis , 2021, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[4]  Inayat Shah,et al.  Acetyl-l-Carnitine Ameliorates Metabolic and Endocrine Alterations in Women with PCOS: A Double-Blind Randomized Clinical Trial , 2021, Advances in Therapy.

[5]  E. Mayo-Wilson,et al.  The PRISMA 2020 statement: an updated guideline for reporting systematic reviews , 2020, BMJ.

[6]  G. Macchiarelli,et al.  Regulatory Functions of L-Carnitine, Acetyl, and Propionyl L-Carnitine in a PCOS Mouse Model: Focus on Antioxidant/Antiglycative Molecular Pathways in the Ovarian Microenvironment , 2020, Antioxidants.

[7]  M. Mohammadi,et al.  Effects of l-carnitine supplementation on weight loss and body composition: A systematic review and meta-analysis of 37 randomized controlled clinical trials with dose-response analysis. , 2020, Clinical nutrition ESPEN.

[8]  A. Sheikhi,et al.  Beneficial Effects of L-Carnitine Supplementation for Weight Management in Overweight and Obese Adults: An Updated Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. , 2019, Pharmacological research.

[9]  A. Sheikhi,et al.  Efficacy of l-carnitine supplementation for management of blood lipids: A systematic review and dose-response meta-analysis of randomized controlled trials. , 2019, Nutrition, metabolism, and cardiovascular diseases : NMCD.

[10]  K. Djafarian,et al.  The effects of supplementation with L-carnitine on apolipoproteins: A systematic review and meta-analysis of randomized trials. , 2019, European journal of pharmacology.

[11]  Ibrahim A. El sharkwy,et al.  l-Carnitine plus metformin in clomiphene-resistant obese PCOS women, reproductive and metabolic effects: a randomized clinical trial , 2019, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[12]  Ibrahim A. El sharkwy,et al.  Randomized controlled trial of N‐acetylcysteine versus l‐carnitine among women with clomiphene‐citrate‐resistant polycystic ovary syndrome , 2019, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[13]  H. Gilasi,et al.  Effects of Carnitine Administration on Carotid Intima-media Thickness and Inflammatory Factors in Patients with Polycystic Ovary Syndrome: A Randomized, Double-blind, Placebo-controlled Trial , 2019, International journal of preventive medicine.

[14]  Z. Asemi,et al.  Effects of Chromium and Carnitine Co-supplementation on Body Weight and Metabolic Profiles in Overweight and Obese Women with Polycystic Ovary Syndrome: a Randomized, Double-Blind, Placebo-Controlled Trial , 2019, Biological Trace Element Research.

[15]  A. Agarwal,et al.  Double‐blind, randomised, placebo‐controlled trial on the effect of L‐carnitine and L‐acetylcarnitine on sperm parameters in men with idiopathic oligoasthenozoospermia , 2019, Andrologia.

[16]  A. Yaba,et al.  The effect of nutrient supplementation in the management of polycystic ovary syndrome-associated metabolic dysfunctions: A critical review , 2018, Journal of the Turkish German Gynecological Association.

[17]  J. Rahmani,et al.  The effect of l-carnitine supplementation on serum leptin concentrations: a systematic review and meta-analysis of randomized controlled trials , 2018, Endocrine.

[18]  Y. Morimoto,et al.  Oral administration of l-carnitine improves the clinical outcome of fertility in patients with IVF treatment , 2018, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[19]  Yongfei Tan,et al.  L-carnitine treatment of insulin resistance: A systematic review and meta-analysis. , 2017, Advances in clinical and experimental medicine : official organ Wroclaw Medical University.

[20]  Z. Asemi,et al.  Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial , 2017, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.

[21]  Z. Asemi,et al.  Oral carnitine supplementation reduces body weight and insulin resistance in women with polycystic ovary syndrome: a randomized, double‐blind, placebo‐controlled trial , 2016, Clinical endocrinology.

[22]  P. Navarro,et al.  Treatment of infertility in women with polycystic ovary syndrome: approach to clinical practice , 2015, Clinics.

[23]  Tiejun Tong,et al.  Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range , 2015, Statistical methods in medical research.

[24]  R. Brannigan,et al.  Metabolic syndrome and infertility in men. , 2015, Best practice & research. Clinical obstetrics & gynaecology.

[25]  S. Saso,et al.  Adding L-carnitine to clomiphene resistant PCOS women improves the quality of ovulation and the pregnancy rate. A randomized clinical trial. , 2014, European journal of obstetrics, gynecology, and reproductive biology.

[26]  Jiming Liu,et al.  Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range , 2014, BMC Medical Research Methodology.

[27]  Kristen A Pate,et al.  Epidemiology, diagnosis, and management of polycystic ovary syndrome. , 2013, Clinical epidemiology.

[28]  C. Martínez-Faedo,et al.  Metabolic effects of L-carnitine on type 2 diabetes mellitus: systematic review and meta-analysis. , 2013, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[29]  J. Sterne,et al.  The Cochrane Collaboration’s tool for assessing risk of bias in randomised trials , 2011, BMJ : British Medical Journal.

[30]  L. Moran,et al.  Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. , 2010, Human reproduction update.

[31]  E. Martínez-Abundis,et al.  Effect of Oral L-Carnitine Administration on Insulin Sensitivity and Lipid Profile in Type 2 Diabetes Mellitus Patients , 2008, Annals of Nutrition and Metabolism.

[32]  Raghu Kacker,et al.  Random-effects model for meta-analysis of clinical trials: an update. , 2007, Contemporary clinical trials.

[33]  G. Risuleo,et al.  Reduction of apoptosis through the mitochondrial pathway by the administration of acetyl-L-carnitine to mouse fibroblasts in culture. , 2005, Experimental cell research.

[34]  D. Altman,et al.  Measuring inconsistency in meta-analyses , 2003, BMJ : British Medical Journal.

[35]  G. Smith,et al.  Bias in meta-analysis detected by a simple, graphical test , 1997, BMJ.

[36]  A. Milajerdi,et al.  The effects of L-carnitine supplementation on serum lipids: A systematic review and meta-analysis of randomized controlled trials. , 2019, Current pharmaceutical design.

[37]  Anahita Mansoori,et al.  The effect of l-carnitine supplementation on lipid profile and glycaemic control in adults with cardiovascular risk factors: A systematic review and meta-analysis of randomized controlled clinical trials. , 2020, Clinical nutrition.

[38]  K. Park,et al.  Carnitine induces autophagy and restores high-fat diet-induced mitochondrial dysfunction. , 2018, Metabolism: clinical and experimental.

[39]  Mak-Soon Lee,et al.  L-carnitine stimulates lipolysis via induction of the lipolytic gene expression and suppression of the adipogenic gene expression in 3T3-L1 adipocytes. , 2006, Journal of medicinal food.